Physician profile
Augustine K Kabongo
NPI 1467795930
$647.61
in general payments reported to CMS, 2019-2025
9 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $65.92 · 2021: $86.56 · 2022: $139 · 2023: $147 · 2024: $89.15 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $356.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $356.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $241.40 | 2020-2024 | |
| Abbvie INC. | $83.37 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $82.31 | 2020-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $67.72 | 2023 | Hyqvia |
| E.R. Squibb & Sons, L.L.C. | $63.18 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.27 | 2025 | Jardiance |
| Pfizer INC. | $31.10 | 2024-2025 | |
| Novo Nordisk INC | $23.01 | 2023 | Ozempic |
| Chiesi USA, INC. | $20.25 | 2023 | Cleviprex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Augustine Kabongo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.